Amyris delivers record production of cbg for consumer skincare formulations

Emeryville, calif., march 25, 2021 /prnewswire/ -- amyris, inc. (nasdaq: amrs), a leading synthetic biotechnology company active in the clean health and beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced today the achievement of another breakthrough with its production of cannabigerol (cbg) from fermentation for consumer skincare treatment formulations.
AMRS Ratings Summary
AMRS Quant Ranking